tiprankstipranks
Trending News
More News >
Sino Biopharmaceutical Ltd (HK:1177)
:1177
Hong Kong Market

Sino Biopharmaceutical (1177) Financial Statements

Compare
12 Followers

Sino Biopharmaceutical Financial Overview

Sino Biopharmaceutical's market cap is currently $80.12B. The company's EPS TTM is HK$0.0326479086; its P/E ratio is 42.22; and it has a dividend yield of 1.39%. Sino Biopharmaceutical is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is HK$0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 28.87B¥ 26.20B¥ 28.78B¥ 26.86B¥ 23.65B
Gross Profit¥ 23.53B¥ 21.21B¥ 22.98B¥ 21.53B¥ 18.46B
Operating Income¥ 6.28B¥ 5.79B¥ 6.69B¥ 18.86B¥ 4.89B
EBITDA¥ 6.11B¥ 6.98B¥ 6.69B¥ 19.87B¥ 6.54B
Net Income¥ 3.50B¥ 2.33B¥ 5.00B¥ 14.61B¥ 4.34B
Balance Sheet
Cash & Short-Term Investments¥ 14.60B¥ 14.12B¥ 16.92B¥ 15.79B¥ 16.43B
Total Assets¥ 65.41B¥ 63.60B¥ 64.06B¥ 60.54B¥ 47.21B
Total Debt¥ 9.78B¥ 12.58B¥ 13.98B¥ 12.12B¥ 14.21B
Net Debt¥ 214.26M¥ 3.13B¥ 5.33B¥ 2.52B¥ 3.59B
Total Liabilities¥ 22.63B¥ 25.43B¥ 26.12B¥ 22.81B¥ 24.79B
Stockholders' Equity¥ 31.96B¥ 30.47B¥ 29.75B¥ 30.29B¥ 16.75B
Cash Flow
Free Cash Flow¥ 0.00¥ 4.36B¥ 4.56B¥ 3.47B¥ 3.47B
Operating Cash Flow¥ 0.00¥ 6.07B¥ 6.27B¥ 5.37B¥ 5.33B
Investing Cash Flow¥ 0.00¥ -756.98M¥ -4.07B¥ -2.52B¥ -7.85B
Financing Cash Flow¥ 0.00¥ -6.55B¥ -3.19B¥ -3.23B¥ 2.23B
Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Sino Biopharmaceutical Debt to Assets

Sino Biopharmaceutical Cash Flow

Sino Biopharmaceutical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis